1. Home
  2. SLNG vs CTMX Comparison

SLNG vs CTMX Comparison

Compare SLNG & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNG
  • CTMX
  • Stock Information
  • Founded
  • SLNG 2013
  • CTMX 2008
  • Country
  • SLNG United States
  • CTMX United States
  • Employees
  • SLNG N/A
  • CTMX N/A
  • Industry
  • SLNG Oil/Gas Transmission
  • CTMX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SLNG Utilities
  • CTMX Health Care
  • Exchange
  • SLNG Nasdaq
  • CTMX Nasdaq
  • Market Cap
  • SLNG 85.4M
  • CTMX 85.3M
  • IPO Year
  • SLNG N/A
  • CTMX 2015
  • Fundamental
  • Price
  • SLNG $6.48
  • CTMX $0.84
  • Analyst Decision
  • SLNG
  • CTMX Buy
  • Analyst Count
  • SLNG 0
  • CTMX 6
  • Target Price
  • SLNG N/A
  • CTMX $5.77
  • AVG Volume (30 Days)
  • SLNG 15.1K
  • CTMX 1.2M
  • Earning Date
  • SLNG 03-05-2025
  • CTMX 03-10-2025
  • Dividend Yield
  • SLNG N/A
  • CTMX N/A
  • EPS Growth
  • SLNG N/A
  • CTMX N/A
  • EPS
  • SLNG 0.21
  • CTMX 0.16
  • Revenue
  • SLNG $74,044,000.00
  • CTMX $126,617,000.00
  • Revenue This Year
  • SLNG N/A
  • CTMX $22.55
  • Revenue Next Year
  • SLNG N/A
  • CTMX N/A
  • P/E Ratio
  • SLNG $30.94
  • CTMX $5.20
  • Revenue Growth
  • SLNG N/A
  • CTMX 33.66
  • 52 Week Low
  • SLNG $3.77
  • CTMX $0.79
  • 52 Week High
  • SLNG $7.15
  • CTMX $5.85
  • Technical
  • Relative Strength Index (RSI)
  • SLNG 62.64
  • CTMX 33.95
  • Support Level
  • SLNG $5.93
  • CTMX $0.79
  • Resistance Level
  • SLNG $6.29
  • CTMX $1.17
  • Average True Range (ATR)
  • SLNG 0.43
  • CTMX 0.08
  • MACD
  • SLNG 0.02
  • CTMX -0.03
  • Stochastic Oscillator
  • SLNG 64.36
  • CTMX 13.16

About SLNG Stabilis Solutions Inc.

Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. It has a geographical presence in the United States and Mexico.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: